We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

BioCryst Shareholders Sue Over Idera Merger Plan

Law360 (March 8, 2018, 3:33 PM EST) -- BioCryst Pharmaceuticals Inc. and its board of directors have undervalued the biotechnology company by agreeing to a “merger of equals” with Idera Pharmaceuticals Inc., a shareholder says in a proposed class...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Delaware

Nature of Suit

Securities/Commodities

Judge

Subscribers Only

Date Filed

March 6, 2018

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.